147 related articles for article (PubMed ID: 10855258)
1. Nuclear medicine imaging of lung cancer.
Goldsmith SJ; Kostakoglu L
Radiol Clin North Am; 2000 May; 38(3):511-24. PubMed ID: 10855258
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
Goldsmith SJ; Kostakoglu L
Semin Ultrasound CT MR; 2000 Apr; 21(2):129-38. PubMed ID: 10776885
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
6. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
[TBL] [Abstract][Full Text] [Related]
7. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
8. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide imaging of thoracic malignancies.
Goldsmith SJ; Kostakoglu LA; Somrov S; Palestro CJ
Thorac Surg Clin; 2004 Feb; 14(1):95-112. PubMed ID: 15382313
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of integrated (99m)Tc-MIBI-SPECT/localizable CT and integrated ¹⁸F-FDG-PET/CT for differential diagnosis of solitary pulmonary nodules].
Deng Z; Li G; Xiang X; Jia L; Liu C; Chen T; Liu C
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):422-6. PubMed ID: 25818793
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
Grewal RK; Dadparvar S; Yu JQ; Babaria CJ; Cavanaugh T; Sherman M; Jacobstein J
Cancer J; 2002; 8(5):400-4. PubMed ID: 12416898
[TBL] [Abstract][Full Text] [Related]
12. The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.
Wu Q; Zhong L; Xie X
Clin Transl Oncol; 2021 Feb; 23(2):296-310. PubMed ID: 32548796
[TBL] [Abstract][Full Text] [Related]
13. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Cronin P; Dwamena BA; Kelly AM; Carlos RC
Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
16. Limited value of ⁹⁹mTc depreotide single photon emission CT compared with CT for the evaluation of pulmonary lesions.
Harders SW; Madsen HH; Hjorthaug K; Rehling M; Rasmussen TR; Pedersen U; Pilegaard HK; Meldgaard P; Baandrup UT; Rasmussen F
Br J Radiol; 2012 Jul; 85(1015):e307-13. PubMed ID: 22745210
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
18. Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
Ferran N; Ricart Y; Lopez M; Martinez-Ballarin I; Roca M; Gámez C; Carrerea D; Guirao S; Leon AF; Martin-Comin J
Nucl Med Commun; 2006 Jun; 27(6):507-14. PubMed ID: 16710105
[TBL] [Abstract][Full Text] [Related]
19. [The value of FDG-PET/CT in the evaluation of patients with a pulmonary nodule and a previous malignant disease].
Ben-Nun A; Orlovsky M; Best AL; Bar Shalom R
Harefuah; 2006 Oct; 145(10):713-7, 784, 783. PubMed ID: 17111703
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic efficacy of 99Tcm-MIBI SPECT/CT and 18F-FDG coincidence SPECT/CT for solitary pulmonary nodules: a comparative study].
Jia X; Xue JJ; Gao R; Deng HX; Zhang FR; Yang AM
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):386-90. PubMed ID: 27063168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
